The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Abstract
Natural killer cells can discriminate between normal cells and cells that do not express adequate amounts of major histocompatibility complex (MHC) class I molecules. The discovery, both in mouse and in human, of MHC-specific inhibitory receptors clarified the molecular basis of this important NK cell function. However, the triggering receptors responsible for positive NK cell stimulation remained elusive until recently. Some of these receptors have now been identified in humans, thus shedding some light on the molecular mechanisms involved in NK cell activation during the process of natural cytotoxicity. Three novel, NK-specific, triggering surface molecules (NKp46, NKp30, and NKp44) have been identified. They represent the first members of a novel emerging group of receptors collectively termed natural cytotoxicity receptors (NCR). Monoclonal antibodies (mAbs) to NCR block to differing extents the NK-mediated lysis of various tumors. Moreover, lysis of certain tumors can be virtually abrogated by the simultaneous masking of the three NCRs. There is a coordinated surface expression of the three NCRs, their surface density varying in different individuals and also in the NK cells isolated from a given individual. A direct correlation exists between the surface density of NCR and the ability of NK cells to kill various tumors. NKp46 is the only NCR involved in human NK-mediated killing of murine target cells. Accordingly, a homologue of NKp46 has been detected in mouse. Molecular cloning of NCR revealed novel members of the Ig superfamily displaying a low degree of similarity to each other and to known human molecules. NCRs are coupled to different signal transducing adaptor proteins, including CD3ζ, Fc∍RIγ, and KARAP/DAP12. Another triggering NK receptor is NKG2D. It appears to play either a complementary or a synergistic role with NCRs. Thus, the triggering of NK cells in the process of tumor cell lysis may often depend on the concerted action of NCR and NKG2D. In some instances, however, it may uniquely depend upon the activity of NCR or NKG2D only. Strict NKG2D-dependency can be appreciated using clones that, in spite of their NCR dull phenotype, efficiently lyse certain epithelial tumors or leukemic cell lines. Other triggering surface molecules including 2B4 and the novel NKp80 appear to function as coreceptors rather than as true receptors. Indeed, they can induce natural cytotoxicity only when co-engaged with a triggering receptor. While an altered expression or function of NCR or NKG2D is being explored as a possible cause of immunological disorders, 2B4 dysfunction has already been associated with a severe form of immunodeficiency. Indeed, in patients with the X-linked lymphoproliferative disease, the inability to control Epstein-Barr virus infections may be consequent to a major dysfunction of 2B4 that exerts inhibitory instead of activating functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
RAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Shinkai, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90029-c · Cited by 2,150
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
RETH, M. (1989) · Nature · doi:10.1038/338383b0 · Cited by 1,438
Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P., & Samelson, L. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80901-0 · Cited by 1,267
Ravetch, J. V., & Kinet, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002325 · Cited by 1,229
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Self-citationCohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Self-citationViral Strategies of Immune Evasion
Ploegh, H. L. (1998) · Science · doi:10.1126/science.280.5361.248 · Cited by 778
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Self-citationCoffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Self-citationBorrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes
Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)70060-4 · Cited by 641
Plasticity in the organization and sequences of human KIR/ILT gene families
Wilson, M. J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., Beck, S., & Trowsdale, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080588597 · Cited by 624
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Self-citationAssociation of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Self-citationMoretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., & Moretta, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.597 · Cited by 534
Self-citationInactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
A novel receptor involved in T-cell activation
Cocks, B. G., Chang, C.-C. J., Carballido, J. M., Yssel, H., de Vries, J. E., & Aversa, G. (1995) · Nature · doi:10.1038/376260a0 · Cited by 479
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Self-citationCantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452
Self-citationLazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., & Phillips, J. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4741 · Cited by 447
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Self-citationHouchins, J. P., Yabe, T., McSherry, C., & Bach, F. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.1017 · Cited by 447
Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells
Lanier, L. L., Yu, G., & Phillips, J. H. (1989) · Nature · doi:10.1038/342803a0 · Cited by 432
Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1656::aid-immu1656>3.0.co;2-1 · Cited by 422
Self-citationActivation and function of natural killer cell responses during viral infections
Biron, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80155-0 · Cited by 420
2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A., & Neil Barclay, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2083 · Cited by 415
LAIR-1, a Novel Inhibitory Receptor Expressed on Human Mononuclear Leukocytes
Meyaard, L., Adema, G. J., Chang, C., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80530-0 · Cited by 401
The structure and ligand interactions of CD2: implications for T-cell function
Davis, S. J., & van der Merwe, P. A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80617-7 · Cited by 391
Moretta, A., Bottino, C., Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., Barbaresi, M., Merli, A., & Ciccone, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1589 · Cited by 385
Self-citationAuchincloss, H., & Sachs, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.433 · Cited by 372
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., & Moretta, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01596-6 · Cited by 354
Self-citationMoretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
Self-citationHomozygous Human TAP Peptide Transporter Mutation in HLA Class I Deficiency
de la Salle, H., Hanau, D., Fricker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, S. H., Donato, L., Bausinger, H., Laforet, M., et al. (1994) · Science · doi:10.1126/science.7517574 · Cited by 346
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Self-citationCancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
Rosenberg, S. A., & Lotze, M. T. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.003341 · Cited by 314
X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery
Seemayer, T. A., Gross, T. G., Egeler, R. M., Pirruccello, S. J., Davis, J. R., Kelly, C. M., Okano, M., Lanyi, A., & Sumegi, J. (1995) · Pediatric Research · doi:10.1203/00006450-199510000-00001 · Cited by 297
Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.6981 · Cited by 297
Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.60 · Cited by 288
Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez‐Villar, J. J., Moretta, L., Moretta, A., & López‐Botet, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270230 · Cited by 281
Self-citationSiliciano, R. F., Pratt, J. C., Schmidt, R. E., Ritz, J., & Reinherz, E. L. (1985) · Nature · doi:10.1038/317428a0 · Cited by 281
New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL)
Cambier, J. C. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80105-7 · Cited by 268
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262
Self-citationMoretta, A., Tambussi, G., Bottino, C., Tripodi, G., Merli, A., Ciccone, E., Pantaleo, G., & Moretta, L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.695 · Cited by 250
Self-citationArousal and inhibition of human NK cells
Lanier, L. L., Corliss, B., & Phillips, J. H. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00947.x · Cited by 243
Activating interactions in human NK cell recognition: the role of 2B4-CD48
Nakajima, H., Cella, M., Langen, H., Friedlein, A., & Colonna, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1676::aid-immu1676>3.0.co;2-y · Cited by 242
Orloff, D. G., Ra, C., Frank, S. J., Klausner, R. D., & Kinet, J.-P. (1990) · Nature · doi:10.1038/347189a0 · Cited by 241
Mingari, M. C., Schiavetti, F., Ponte, M., Vitale, C., Maggi, E., Romagnani, S., Demarest, J., Pantaleo, G., Fauci, A. S., & Moretta, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12433 · Cited by 240
Self-citationMingari, M. C., Moretta, A., & Moretta, L. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01236-x · Cited by 240
Self-citationThe Molecular and Functional Characterization of a Dominant Minor H Antigen, H60
Malarkannan, S., Shih, P. P., Eden, P. A., Horng, T., Zuberi, A. R., Christianson, G., Roopenian, D., & Shastri, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3501 · Cited by 233
DAP12-Deficient Mice Fail to Develop Autoimmunity Due to Impaired Antigen Priming
Bakker, A. B. H., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, J. H., Sedgwick, J. D., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)00034-0 · Cited by 232
Identification of NKp80, a novel triggering molecule expressed by human NK cells
Vitale, M., Falco, M., Castriconi, R., Parolini, S., Zambello, R., Semenzato, G., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<233::aid-immu233>3.0.co;2-4 · Cited by 223
Self-citationIdentification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
Valiante, N. M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1397 · Cited by 223
Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L., & Moretta, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.793 · Cited by 222
Self-citationInhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271203 · Cited by 213
Self-citationDownregulation of TAP1 in B Lymphocytes by Cellular and Epstein-Barr Virus–Encoded Interleukin-10
Zeidler, R., Eissner, G., Meissner, P., Uebel, S., Tampé, R., Lazis, S., & Hammerschmidt, W. (1997) · Blood · doi:10.1182/blood.v90.6.2390 · Cited by 204
Mathew, P. A., Garni-Wagner, B. A., Land, K., Takashima, A., Stoneman, E., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5328 · Cited by 202
Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain.
Wirthmueller, U., Kurosaki, T., Murakami, M. S., & Ravetch, J. V. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1381 · Cited by 186
Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5809 · Cited by 180
Identification of the 2B4 molecule as a counter-receptor for CD48.
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · PubMed · Cited by 170
Biassoni, R., Pessino, A. M., Bottino, C., Pende, D., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<1014::aid-immu1014>3.0.co;2-o · Cited by 160
Self-citationTomasello, E., Desmoulins, P.-O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D., & Vivier, E. (2000) · Immunity · doi:10.1016/s1074-7613(00)00035-2 · Cited by 159
Ho, E., Heusel, J. W., Brown, M. G., Matsumoto, K., Scalzo, A., & Yokoyama, W. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.11.6320 · Cited by 158
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · Cited by 153
Self-citationFunctional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity
Brumbaugh, K. M., Binstadt, B. A., Billadeau, D. D., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1965 · Cited by 149
Turning on Natural Killer Cells
Lanier, L. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1259 · Cited by 143
Zimmer, J., Donato, L., Hanau, D., Cazenave, J., Tongio, M., Moretta, A., & de la Salle, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.117 · Cited by 139
Self-citationTomasello, E., Bléry, M., Vely, E., & Vivier, É. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0216 · Cited by 136
Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells
Smith, H. R. C., Chuang, H. H., Wang, L. L., Salcedo, M., Heusel, J. W., & Yokoyama, W. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1341 · Cited by 129
Early recognition of a discordant xenogeneic organ by human circulating lymphocytes
Inverardi, L., Samaja, M., Motterlini, R., Mangili, F., Bender, J. R., & Pardi, R. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1416 · Cited by 124
Bléry, M., Delon, J., Trautmann, A., Cambiaggi, A., Olcese, L., Biassoni, R., Moretta, L., Chavrier, P., Moretta, A., Daëron, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8989 · Cited by 124
Self-citationChang, C., Dietrich, J., Harpur, A. G., Lindquist, J. A., Haude, A., Loke, Y. W., King, A., Colonna, M., Trowsdale, J., & Wilson, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4651 · Cited by 120
Campbell, K. S., Cella, M., Carretero, M., López-Botet, M., & Colonna, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<599::aid-immu599>3.0.co;2-f · Cited by 114
Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells.
Salcedo, T. W., Kurosaki, T., Kanakaraj, P., Ravetch, J. V., & PERUSSIA, B. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.5.1475 · Cited by 113
Bottino, C., Biassoni, R., Millo, R., Moretta, L., & Moretta, A. (2000) · Human Immunology · doi:10.1016/s0198-8859(99)00162-7 · Cited by 108
Self-citationXenogeneic human anti‐pig cytotoxicity mediated by activated natural killer cells
Seebach, J. D., Yamada, K., McMorrow, I. M., Sachs, D. H., & Dersimonian, H. (1996) · Xenotransplantation · doi:10.1111/j.1399-3089.1996.tb00137.x · Cited by 107
Ting, A. T., Dick, C. J., Schoon, R. A., Karnitz, L. M., Abraham, R. T., & Leibson, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16415 · Cited by 99
Nomura, M., Zou, Z., Joh, T., Takihara, Y., Matsuda, Y., & Shimada, K. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021517 · Cited by 99
Bolhuis, R. L. H., Roozemond, R. C., & van de Griend, R. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.3939 · Cited by 93
Bottino, C., Augugliaro, R., Castriconi, R., Nanni, M., Biassoni, R., Moretta, L., & Moretta, A. (2000) · European Journal of Immunology · Cited by 86
Self-citationX-linked lymphoproliferative syndrome.
Jl, S., & Ba, W. (1989) · PubMed · Cited by 79
Neville, M. J., & Campbell, R. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4745 · Cited by 76
Cloning of NKG2‐F, a new member of the NKG2 family of human natural killer cell receptor genes
Plougastel-Douglas, B., & Trowsdale, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271114 · Cited by 73
Poggi, A. D., Pella, N., Morelli, L., Spada, F. M., Revello, V., Sivori, S., Augugliaro, R., Moretta, L., & Moretta, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250210 · Cited by 70
Self-citationCone, J. C., Lu, Y., Trevillyan, J. M., Bjorndahl, J. M., & Phillips, C. A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231017 · Cited by 54
T Cell Development in Mice Lacking All T Cell Receptor ζ Family Members (ζ, η, and FcεRIγ)
Shores, E. W., Ono, M., Kawabe, T., Sommers, C. L., Tran, T., Lui, K., Udey, M. C., Ravetch, J. V., & Love, P. E. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1093 · Cited by 47
Activation of murine epidermal γδ T cells through surface 2B4
Schuhmachers, G., Ariizumi, K., Mathew, P. A., Bennett, M., Kumar, Y., & Takashima, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250440 · Cited by 44
Ståhls, A., Liwszyc, G. E., Couture, C., Mustelin, T., & Andersson, L. C. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241035 · Cited by 44
Morrison, D. F., Ting, T. D., Vallury, V., Ho, Y.-K., Crouch, R. K., Corson, D. W., Mangini, N. J., & Pepperberg, D. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6718 · Cited by 27
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Self-citationThe biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Metadata
- Authors
- Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2001-04
- Volume
- 19
- Issue
- 1
- Pages
- 197-223
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2130649175
- Cited by
- 1,778
- References
- 110
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.